Davis Capital Management’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.1K Buy
212
+9
+4% +$351 0.01% 257
2026
Q1
$7.18K Hold
203
﹤0.01% 234
2025
Q4
$5.68K Hold
203
﹤0.01% 250
2025
Q3
$6.09K Buy
+203
New +$5.72K ﹤0.01% 250
2025
Q1
$6.7K Hold
203
0.01% 240
2024
Q4
$5.84K Hold
203
﹤0.01% 253
2024
Q3
$5.68K Hold
203
﹤0.01% 263
2024
Q2
$4.95K Hold
203
﹤0.01% 265
2024
Q1
$5.53K Hold
203
﹤0.01% 240
2023
Q4
$5.63K Buy
+203
New +$5.27K 0.01% 238

Other funds holding ALKS

Davis Capital Management's ALKS Position: Q2 2026 in Review

Davis Capital Management increased its Alkermes (ALKS) stake by 4.4% in Q2 2026, buying an estimated $351 and bringing the position to 212 shares worth $11.1K. The position accounts for 0.01% of the portfolio, ranked #257.

Davis Capital Management first reported a position in ALKS in Q4 2023 and has held it in 10 quarters since. 68 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Davis Capital Management held 212 shares of Alkermes worth $11.1K as of Q2 2026.
  • Davis Capital Management bought 9 Alkermes shares in Q2 2026, an estimated $351.
  • Alkermes made up 0.01% of Davis Capital Management's portfolio in Q2 2026, its #257 holding.
  • Davis Capital Management first reported a position in Alkermes in Q4 2023 and has held it in 10 quarters since.
  • 68 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.